Phase I Trial of AVD Plus Lenalidomide (Revlimid) in Elderly Intermediate or Advanced Stage Hodgkin Lymphoma Patients.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Lenalidomide (Primary) ; Dacarbazine; Doxorubicin; Vinblastine
- Indications Hodgkin's disease
- Focus Adverse reactions
- 30 Nov 2015 Planned End Date changed from 1 Apr 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.
- 25 Jan 2013 Planned end date added (1 Apr 2014) as reported by ClinicalTrials.gov.
- 25 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.